GRIM
STLNW

Greenhaven Road Investment Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Greenhaven Road Investment Management’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,003
Closed -$32K – 60
2021
Q4 		$32K Buy
+47,003
New +$58.1K 0.01% 45

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
USPCM
Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Greenhaven Road Investment Management's STLNW Position: Q1 2022 in Review

Greenhaven Road Investment Management sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2022, closing a stake of 47,003 shares — an estimated $32K sold.

Greenhaven Road Investment Management first reported a position in STLNW in Q4 2021 and held it in 1 quarter. The position peaked at $32K in Q4 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q1 2022.

  • Greenhaven Road Investment Management reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Greenhaven Road Investment Management sold 47,003 Starling Oncology, Inc. Warrant shares in Q1 2022, an estimated $32K.
  • Greenhaven Road Investment Management first reported a position in Starling Oncology, Inc. Warrant in Q4 2021 and held it in 1 quarter.
  • Greenhaven Road Investment Management's Starling Oncology, Inc. Warrant position peaked at $32K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2022.

Based on Greenhaven Road Investment Management's 13F filing for Q1 2022, filed 16 May 2022.